Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10253)
All Articles published online
|
Publishing Process of This Article
|
Nov 6, 2020 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Dajani AI, Popovic B. Essential phospholipids for nonalcoholic fatty liver disease associated with metabolic syndrome: A systematic review and network meta-analysis. World J Clin Cases 2020; 8(21): 5235-5249 [PMID: 33269259 DOI: 10.12998/wjcc.v8.i21.5235] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v8/i21/5235.htm |
| Number | Citing Articles |
| 1 |
L. B. Lazebnik, E. V. Golovanova, S. V. Turkina, K. L. Raikhelson, S. V. Okovityy, O. M. Drapkina, I. V. Maev, A. I. Martynov, G. E. Roitberg, O. V. Khlynova, D. I. Abdulganieva, S. A. Alekseenko, M. D. Ardatskaya, I. G. Bakulin, N. V. Bakulina, A. O. Bueverov, E. V. Vinitskaya, G. V. Volynets, E. Yu. Eremina, V. B. Grinevich, A. I. Dolgushina, A. N. Kazyulin, E. I. Kashkina, I. V. Kozlova, Yu. V. Konev, N. V. Korochanskaya, Yu. A. Kravchuk, E. D. Li, I. D. Loranskaya, V. M. Makhov, S. N. Mekhtiev, V. P. Novikova, O. D. Ostroumova, Ch. S. Pavlov, V. G. Radchenko, A. A. Samsonov, A. S. Sarsenbaeva, R. G. Sayfutdinov, P. V. Seliverstov, S. I. Sitkin, O. V. Stefanyuk, L. V. Tarasova, E. I. Tkachenko, Yu. P. Uspensky, Yu. A. Fominykh, A. I. Khavkin, Yu. V. Tsyganova, O. O. Sharhun. Non-alcoholic fatty liver disease in adults: clinic, diagnostics, treatment. Guidelines for therapists, third version. Experimental and Clinical Gastroenterology 2021; 1(1): 4 doi: 10.31146/1682-8658-ecg-185-1-4-52
|
| 2 |
Dominik Wupperfeld, Gert Fricker, Béatrice Bois De Fer, Branko Popovic. Essential phospholipids impact cytokine secretion and alter lipid-metabolizing enzymes in human hepatocyte cell lines. Pharmacological Reports 2024; 76(3): 572 doi: 10.1007/s43440-024-00595-4
|
| 3 |
Daria A. Teplyuk, Aliya A. Kaisina, Shabnam I. Ibragimova, Afina A. Bestavashvili, Irina O. Tinkova, Evgeniia Iu. Pashkova, Jamilya A. Kaibullayeva, Alexander V. Nersesov, Chavdar S. Pavlov. Non-alcoholic fatty liver disease: from understanding risk factors to finding optimal treatment regimens: A review. Consilium Medicum 2023; 25(5): 325 doi: 10.26442/20751753.2023.5.202272
|
| 4 |
Inês Domingues, Hafsa Yagoubi, Wunan Zhang, Valentina Marotti, Espoir K. Kambale, Katlijn Vints, Malgorzata Alicja Sliwinska, Isabelle A. Leclercq, Ana Beloqui. Effects of semaglutide-loaded lipid nanocapsules on metabolic dysfunction-associated steatotic liver disease. Drug Delivery and Translational Research 2024; 14(10): 2917 doi: 10.1007/s13346-024-01576-z
|
| 5 |
VIKTOR TOMCHUK, ANDRII POTOTSKYI, VIKTORIIA GRYSHCHENKO, STANISLAV VESELSKYI, YEVDOKIIA RESHETNIK. CORRECTION OF TRIACYLGLYCEROLS AND FREE FATTY ACIDS IN RAT BILE IN EXPERIMENTAL HEPATIC STEATOSIS. Ukrainian journal of veterinary sciences 2022; 13(2) doi: 10.31548/ujvs.13(2).2022.53-62
|
| 6 |
E. V. Biryukova. Non-alcoholic fatty liver disease: a current challenge of interdisciplinary research. Meditsinskiy sovet = Medical Council 2024; (6): 72 doi: 10.21518/ms2024-159
|
| 7 |
Ekaterina Demicheva, Vladislav Dordiuk, Fernando Polanco Espino, Konstantin Ushenin, Saied Aboushanab, Vadim Shevyrin, Aleksey Buhler, Elena Mukhlynina, Olga Solovyova, Irina Danilova, Elena Kovaleva. Advances in Mass Spectrometry-Based Blood Metabolomics Profiling for Non-Cancer Diseases: A Comprehensive Review. Metabolites 2024; 14(1): 54 doi: 10.3390/metabo14010054
|
| 8 |
Ludovico Abenavoli, Giuseppe La Torre, Natasa Milic. Comment on Clayton-Chubb et al. Understanding NAFLD: From Case Identification to Interventions, Outcomes, and Future Perspectives. Nutrients 2023, 15, 687. Nutrients 2023; 15(13): 2907 doi: 10.3390/nu15132907
|
| 9 |
Dominik Wupperfeld, Gert Fricker, Béatrice Bois De Fer, Larissa Frank, Annika Wehrle, Branko Popovic. Essential phospholipids decrease apoptosis and increase membrane transport in human hepatocyte cell lines. Lipids in Health and Disease 2022; 21(1) doi: 10.1186/s12944-022-01698-8
|
| 10 |
Marek Hartleb, Agnieszka Mastalerz-Migas, Piotr Kowalski, Bogusław Okopień, Branko Popovic, Katarzyna Proga, Beata Cywińska-Durczak. Healthcare practitioners’ diagnostic and treatment practice patterns of nonalcoholic fatty liver disease in Poland: a cross-sectional survey. European Journal of Gastroenterology & Hepatology 2022; 34(4): 426 doi: 10.1097/MEG.0000000000002288
|
| 11 |
Vladimir T. Ivashkin, Marina V. Maevskaya, Elena N. Shirokova, Igor V. Maev, Alexey A. Samsonov, Evgeniy I. Sas, Liudmila K. Palgova, Kirill Starostin. Correlation of Objective Endpoints and Subjective Patient-Reported Outcomes in NAFLD Treatment with Essential Phospholipids: Real-World Data Based on Pooled Analysis of Observational Studies. Drugs - Real World Outcomes 2021; 8(3): 369 doi: 10.1007/s40801-021-00250-x
|
| 12 |
Stanislav Veselskyi, Andrii Pototskyi, Viktor Tomchuk, Viktoriia Gryshchenko, Yevdokiia Reshetnik. Phospholipid composition of bile and blood in rats under correction of experimental fatty hepatosis. Ukrainian journal of veterinary sciences 2023; 14(3): 25 doi: 10.31548/veterinary3.2023.25
|
| 13 |
Asad Izziddin Dajani, Adnan Abuhammour. Agents for the treatment of fatty liver disease: focus on essential phospholipids. Drugs & Therapy Perspectives 2021; 37(6): 249 doi: 10.1007/s40267-021-00838-x
|
| 14 |
V. A. Prikhodko, S. V. Okovityi. Pharmacodynamic and pharmacokinetic aspects of combined use of glycyrrhizinic acid. Experimental and Clinical Gastroenterology 2023; (8): 141 doi: 10.31146/1682-8658-ecg-216-8-141-150
|
| 15 |
S. V. Bulgakova, Yu. A. Dolgikh, L. A. Sharonova, O. V. Kosareva, E. V. Treneva, P. Ya. Merzlova, D. P. Kurmayev. Modern aspects of therapy of metabolic associated liver disease in patients with type 2 diabetes mellitus. Meditsinskiy sovet = Medical Council 2024; (16): 184 doi: 10.21518/ms2024-414
|
| 16 |
Inês Domingues, Isabelle A. Leclercq, Ana Beloqui. Nonalcoholic fatty liver disease: Current therapies and future perspectives in drug delivery. Journal of Controlled Release 2023; 363: 415 doi: 10.1016/j.jconrel.2023.09.040
|
| 17 |
V. A. Gryshchenko, O. О. Danchenko, S. A. Tkachuk, T. I. Fotina, V. V. Zazharskyi, V. V. Brygadyrenko. Lipid composition of blood plasma and epithelium of the jejunal mucosa in calves with dyspepsia and its correction . Regulatory Mechanisms in Biosystems 2023; 14(2): 319 doi: 10.15421/022347
|
| 18 |
Ki M. Mak, Aditya C. Shekhar. Soybean polyenylphosphatidylcholine (PPC) is beneficial in liver and extrahepatic tissue injury: An update in experimental research. The Anatomical Record 2024; 307(6): 2162 doi: 10.1002/ar.25333
|
| 19 |
D. A. Teplyuk, M. Ch. Semenistaya, S. M. Sorokoletov, L. B. Lazebnik, Ch. S. Pavlov. Nonalcoholic liver disease: review with a focus on risks of progression. Experimental and Clinical Gastroenterology 2021; (8): 167 doi: 10.31146/1682-8658-ecg-192-8-167-174
|
| 20 |
Sergey V. Okovityi, Karina L. Raikhelson, Veronika A. Prikhodko. Combined hepatoprotective pharmacotherapy for liver disease. Experimental and Clinical Gastroenterology 2022; (7): 5 doi: 10.31146/1682-8658-ecg-203-7-5-20
|
| 21 |
Iryna Klymas, Liudmyla Khimion. Aminotransferases activity on additional therapy in rheumatoid arthritis patients with liver disease.. Journal of Clinical Medicine of Kazakhstan 2024; 21(2): 89 doi: 10.23950/jcmk/14398
|
| 22 |
Thomai Mouskeftara, Georgios Kalopitas, Theodoros Liapikos, Konstantinos Arvanitakis, Georgios Germanidis, Helen Gika. Predicting Non-Alcoholic Steatohepatitis: A Lipidomics-Driven Machine Learning Approach. International Journal of Molecular Sciences 2024; 25(11): 5965 doi: 10.3390/ijms25115965
|
| 23 |
Tatiana Y. Demidova, Fatima O. Ushanova. Non-alcoholic fatty liver disease: aspects of management of a comorbid patient. A review. Terapevticheskii arkhiv 2023; 95(10): 888 doi: 10.26442/00403660.2023.10.202435
|
| 24 |
D. Osipova, K. Kokoreva, L. Lazebnik, E. Golovanova, Ch. Pavlov, A. Dukhanin, S. Orlova, K. Starostin. Regression of Liver Steatosis Following Phosphatidylcholine Administration: A Review of Molecular and Metabolic Pathways Involved. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.797923
|
| 25 |
Hui Peng, Jiangyuan Li, Huiting Xu, Xian Wang, Leya He, Naomi McCauley, Ke K. Zhang, Linglin Xie. Offspring NAFLD liver phospholipid profiles are differentially programmed by maternal high-fat diet and maternal one carbon supplement. The Journal of Nutritional Biochemistry 2023; 111: 109187 doi: 10.1016/j.jnutbio.2022.109187
|